QSAM Biosciences to Provide Updates on its Clinical Trial at the Emerging Growth Conference on Wednesday, March 22, 2023
QSAM invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.
Related news for (QSAM)
- QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER
- QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
- QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee
- QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
- QSAM Biosciences Expands its Study of CycloSam® in the Treatment of Bone Cancer; Opens Patient Enrollment at Key Chicago Center, Insight Hospital and Medical Center